Contract for the supply of Meningococcal ACWY Vaccine. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

The provision of a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 3 500 000 doses of vaccine.